Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-50,000
Closed -$6.19M 20
2024
Q2
$6.19M Sell
50,000
-60,000
-55% -$7.73M 0.05% 17
2024
Q1
$14.5M Buy
+110,000
New +$13.6M 0.12% 13
2014
Q2
Sell
-7,852
Closed -$425K 208
2014
Q1
$425K Sell
7,852
-9,201
-54% -$476K ﹤0.01% 142
2013
Q4
$814K Buy
17,053
+9,736
+133% +$445K ﹤0.01% 120
2013
Q3
$332K Hold
7,317
﹤0.01% 142
2013
Q2
$324K Buy
+7,317
New +$327K ﹤0.01% 136

Other funds holding MRK

Loews Corp's MRK Position: Q3 2024 in Review

Loews Corp sold out of Merck (MRK) in Q3 2024, closing a stake of 50,000 shares — an estimated $6.19M sold.

Loews Corp first reported a position in MRK in Q2 2013 and held it in 6 quarters. The position peaked at $14.5M in Q1 2024. 3,496 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Loews Corp reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Loews Corp sold 50,000 Merck shares in Q3 2024, an estimated $6.19M.
  • Loews Corp first reported a position in Merck in Q2 2013 and held it in 6 quarters.
  • Loews Corp's Merck position peaked at $14.5M in Q1 2024.
  • 3,496 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Loews Corp's 13F filing for Q3 2024, filed 14 Nov 2024.